Sanara MedTech Inc.SMTINASDAQ
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -18.12% |
| Q2 2025 | 12.87% |
| Q1 2025 | -53.81% |
| Q4 2024 | 77.41% |
| Q3 2024 | 37.93% |
| Q2 2024 | 4.16% |
| Q1 2024 | 45.24% |
| Q4 2023 | -33.95% |
| Q3 2023 | -16.20% |
| Q2 2023 | -10.64% |
| Q1 2023 | 27.40% |
| Q4 2022 | -2.58% |
| Q3 2022 | -0.53% |
| Q2 2022 | 421.41% |
| Q1 2022 | -31.98% |
| Q4 2021 | 743.29% |
| Q3 2021 | -65.69% |
| Q2 2021 | -12.04% |
| Q1 2021 | 305.28% |
| Q4 2020 | 164.63% |
| Q3 2020 | -73.45% |
| Q2 2020 | 846.34% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |